RNS Number : 3189V Stifel Nicolaus Europe Limited 05 July 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 1713V Stifel Nicolaus Europe Limited 04 July 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 9869U Stifel Nicolaus Europe Limited 03 July 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 9828U Stifel Nicolaus Europe Limited 03 July 2024 FORM 8.5 (EPT/RI) REPLACEMENT The Form 8.5 (EPT/RI) - Renalytix announcement released on 02/07/2024 under RNS No 7801U has been amended. Amendments are identified with an asterisk (*). FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE
RNS Number : 7801U Stifel Nicolaus Europe Limited 02 July 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 5623U Stifel Nicolaus Europe Limited 01 July 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
RNS Number : 4769U Renalytix PLC 01 July 2024 Renalytix plc ("Renalytix" or the "Company") Admission of the Second Tranche Placing Shares LONDON and NEW YORK - 1 July 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) confirms that, further to the announcements made on 12 March 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 3407U Stifel Nicolaus Europe Limited 28 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of
